Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicrons

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 8, 1997, Pages 1545-1549

  Olivecrona, Gunilla ^a   Beisiegel, Ulrike ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

ApoIipoprotein CII; Chylomicrons; Lipid binding; Lipoprotein lipase

Indexed keywords

APOLIPOPROTEIN C2; CHYLOMICRON; LIPOPROTEIN LIPASE;

ARTICLE; ENZYME ACTIVATION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID TRANSPORT; NONHUMAN; PRIORITY JOURNAL;

EID: 0030886302     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.8.1545     Document Type: Article

References (21)

1. Havel RJ, Shore VG, Shore B, Bier DM. Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase. Circ Res. 1970;27:595-600.
2. LaRosa JC, Levy RI, Herbert P, Lux SE, Fredrickson DS. A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun. 1970;41:57-62.
3. Smith LC, Pownall HJ. Lipoprotein lipase. In: Borgström B, Brockman H, eds. Lipases. Amsterdam, Netherlands: Elsevier; 1984:263-305.
4. McLean LR, Demel RA, Socorro L, Shinomiya M, Jackson RL. Mechanism of action of lipoprotein lipase. Methods Enzymol. 1986;129:738-765.
5. Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase from milk: the model enzyme in lipoprotein lipase research. In: Borensztajn J, ed. Lipoprotein Lipase. Chicago, Ill: Evener Publishers; 1987:15-58.
6. Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med. 1978;298:1265-1273.
7. Fojo SS, Brewer HB Jr. The familial hyperchylomicronemia syndrome: new insights into underlying genetic defects. JAMA. 1991;265:904-908.
8. Fojo SS, De Gennes JL, Beisiegel U, et al. Molecular genetics of apoC-II and lipoprotein lipase deficiency. Adv Exp Med Biol. 1991;285:329-333.
9. Baggio G, Manzato E, Gabelli C, et al. Apolipoprotein C-II deficiency syndrome: clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two afflicted patients. J Clin Invest. 1986;77:520-527.
10. Beil FU, Fojo SS, Brewer HB Jr, Greten H, Beisiegel U. Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism. Eur J Clin Invest. 1992;22:88-95.
11. Hospattankar AV, Fairwell T, Ronan R, Brewer HB Jr. Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects. J Biol Chem. 1984;259:318-322.
12. Smith LC, Voyta JC, Catapano AL, Kinnunen PKJ, Gotto AM Jr, Sparrow JT. Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II. Ann N Y Acad Sci. 1980;348:213-221.
13. Vainio P, Virtanen JA, Kinnunen PKJ, et al. Action of lipoprotein lipase on phospholipid monolayers: activation by apolipoprotein C-II. Biochemistry. 1983;22:2270-2275.
14. Lycksell PO, Öhman A, Bengtsson-Olivecrona G, et al. Sequence specific 1H-NMR assignments and secondary structure of a carboxy-terminal functional fragment of apolipoprotein CII. Eur J Biochem. 1992;205:223-231.
15. Balasubramaniam A, Rechtin A, McLean LR, Jackson RL, Demel RA. Activation of lipoprotein lipase by N-alpha-palmitoyl (56-79) fragment of apolipoprotein C-II. Biochem Biophys Res Commun. 1986;137:1041-1048.
16. Rapp D, Olivecrona T. Kinetics of milk lipoprotein lipase: studies with tributyrin. Eur J Biochem. 1978;91:379-385.
17. Catapano AL, Kinnunen PKJ, Breckenridge WC, et al. Lipolysis of apoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. Biochem Biophys Res Commun, 1979;89:951-957.
18. Matsuoka N, Shirai K, Johnson JD, et al. Effects of apolipoprotein C-II (apo C-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients. Metabolism. 1981;30:818-824.
19. Haberbosch W, Poli A, Baggio G, Fellin R, Gnasso A, Augustin J. Apolipoprotein C-II deficiency: the role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins. Biochim Biophys Acta. 1984;793:49-60.
20. Jackson RL, Tajima S, Yamamura T, Yokoyama S, Yamamoto A. Comparison of apolipoprotein C-II-defident triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabiltzed particles as substrates for lipoprotein lipase. Biochim Biophys Acta. 1986;875:211-219.
21. Fojo SS, Beisiegel U, Beil U, et al. Donor splice site mutation in the apolipoprotein (apo) C-II gene (apoC-IIHamburg) of a patient with apoC-II deficiency. J Clin Invest. 1988;82:1489-1494.